PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 232 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,897,773 | -48.9% | 6,933,865 | -18.6% | 1.93% | -41.5% |
| Q2 2023 | $113,284,399 | -19.1% | 8,517,624 | -29.6% | 3.30% | -12.8% |
| Q1 2023 | $140,094,388 | +14.1% | 12,097,961 | -19.4% | 3.79% | +15.8% |
| Q4 2022 | $122,742,348 | +4.4% | 15,005,177 | -25.9% | 3.27% | +6.1% |
| Q3 2022 | $117,598,000 | +16.9% | 20,258,099 | -11.0% | 3.08% | +31.2% |
| Q2 2022 | $100,608,000 | -51.0% | 22,762,042 | +1.0% | 2.35% | +15.4% |
| Q1 2022 | $205,137,000 | -30.9% | 22,542,589 | +55.4% | 2.04% | -18.4% |
| Q4 2021 | $296,734,000 | -20.1% | 14,503,169 | -0.2% | 2.49% | +5.9% |
| Q3 2021 | $371,411,000 | -28.4% | 14,536,671 | -2.0% | 2.36% | -20.5% |
| Q2 2021 | $518,832,000 | +20.6% | 14,836,494 | +14.9% | 2.96% | +21.3% |
| Q1 2021 | $430,088,000 | +23.0% | 12,911,695 | -4.2% | 2.44% | +75.4% |
| Q4 2020 | $349,526,000 | – | 13,474,438 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |